To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC67226 | 3D-MPLA Featured |
3D-Monophosphoryl Lipid A-5 (3D-MPLA-5) is a TLR agonist that can be used as an adjuvant for vaccines to enhance their immunogenicity.
More description
|
|
| DC67225 | 3D-MPL(12;16) Featured |
3D-Monophosphoryl Lipid (12,16) (3D-MPL (12,16)) free acid is a TLR agonist that can be used as a vaccine adjuvant to enhance the immunogenicity of vaccines[1].
More description
|
|
| DC67224 | 3D-Monophosphoryl Lipid (14) Featured |
3D-Monophosphoryl Lipid (14) (3D-MPL (14)) is a biochemical reagent.
More description
|
|
| DC67223 | Monophosphoryl Lipid A-12 Featured |
Monophosphoryl Lipid A-12 (MPLA-12) is a biochemical reagent.
More description
|
|
| DC46463 | Monophosphoryl lipid A Featured |
Monophosphoryl lipid A (Glucopyranosyl lipid A) is a toll-like receptor 4 agonist. Monophosphoryl lipid A is derived from the cell wall of nonpathogenic Salmonella. Monophosphoryl lipid A can be used for the research of immunization and vaccine.
More description
|
|
| DC28932 | Polyinosinic-polycytidylic acid sodium Featured |
Polyinosinic-polycytidylic acid (Poly(I:C)) sodium is a synthetic analog of double-stranded RNA and an agonist of toll-like receptor 3 (TLR3) and retinoic acid inducible gene I (RIG-I)-like receptors (RIG-I and MDA5). Polyinosinic-polycytidylic acid sodium can be used as a vaccine adjuvant to enhance innate and adaptive immune responses, and to alter the tumor microenvironment. Polyinosinic-polycytidylic acid sodium can directly trigger cancer cells to undergo apoptosis.
More description
|
|
